The forecast data for the upcoming years indicate a steady increase in the use of respiratory system medicine in Spain: from 113.6 units in 2024, rising to 118.9 units by 2028. This shows a clear upward trend with year-on-year percentage changes of approximately 1.1% from 2024 to 2025, 1.2% from 2025 to 2026, 1.1% from 2026 to 2027, and 1.1% from 2027 to 2028. Over the analyzed five-year period, the compound annual growth rate (CAGR) is estimated to be around 1.14%.
Future trends to watch include advancements in respiratory treatments, the impact of emerging respiratory diseases, demographic changes such as aging population, and policy shifts towards healthcare accessibility, all of which could influence the demand dynamics for respiratory system medicine in Spain.
